Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Should Age 65 be a cutoff for Primary Progressive Multiple Sclerosis therapy? Real World Data is Critical.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2023
Same author

Common Neurologic Features of Lyme Disease That May Present to a Rheumatologist.

Pathogens (Basel, Switzerland)·2023
Same author

Therapy Optimization in Multiple Sclerosis: a cohort study of therapy adherence and risk of relapse.

Multiple sclerosis and related disorders·2015
Same author

Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.

BMJ open·2014
Same author

Disease-modifying agents in multiple sclerosis.

Annals of Indian Academy of Neurology·2010
Same author

Invited article: The ABPN maintenance of certification program for neurologists: past, present, and future.

Neurology·2008
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Pregnancy and multiple sclerosis.

P K Coyle1

  • 1Department of Neurology, Stony Brook MS Comprehensive Care Center, Stony Brook University, Stony Brook, NY 11794-8121, USA. patricia.coyle@stonybrookmedicine.edu

Neurologic Clinics
|July 31, 2012
PubMed
Summary
This summary is machine-generated.

Pregnancy significantly impacts multiple sclerosis (MS) by reducing disease activity, especially in the third trimester. However, a temporary increase in MS activity occurs postpartum, influencing patient care and treatment decisions.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Experiment Videos

Last Updated: May 20, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Area of Science:

  • Neurology
  • Reproductive Medicine
  • Immunology

Background:

  • Multiple sclerosis (MS) typically affects young women of childbearing age.
  • Pregnancy is a critical consideration in the management of MS.
  • Understanding the pregnancy-MS relationship is vital for patient care.

Purpose of the Study:

  • To review the effects of pregnancy on multiple sclerosis.
  • To analyze disease activity changes during and after pregnancy in MS patients.

Main Methods:

  • Literature review on pregnancy and multiple sclerosis.
  • Analysis of disease activity patterns in relation to gestational stage and postpartum period.

Main Results:

  • Disease activity in multiple sclerosis notably decreases during pregnancy, particularly in the last trimester.
  • A transient rebound in disease activity is observed in the first three months postpartum.
  • Pregnancy and the postpartum period necessitate careful counseling and therapeutic strategies.

Conclusions:

  • Pregnancy generally has a protective effect on multiple sclerosis disease activity.
  • Postpartum period requires vigilant monitoring and management adjustments for MS patients.
  • Informed decision-making regarding counseling and treatment is essential for women with MS undergoing pregnancy.